Advancements Set Stage for Future Growth and Enhanced AI eHealth Solutions
VANCOUVER, British Columbia, April 11, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, proudly presents its corporate update, reflecting a year of growth and strategic achievements. UniDoc, dedicated to advancing healthcare access through technology, is transitioning from its development phase to a commercialization phase, marking a new era of growth and innovation.
Key Takeaways:
- Integration of AI technology through a partnership with DocBox Inc., enhancing eHealth capabilities.
- Strategic OEM Agreement with HP Inc. to integrate and sell HP products globally, expanding UniDoc’s reach and product offerings.
- Agreement with MediOrbis, LLC to access a global network of primary care and specialty physicians.
UniDoc CEO Antonio Baldassare shares his excitement, “Last year was a pivotal period for UniDoc, filled with positive developments that have propelled us from the development phase into commercialization. We’ve never been more excited about the future. The integration of DocBox’s AI into our advanced eHealth platform and our strategic partnerships with industry leaders like HP and MediOrbis are advancing the way healthcare is accessed and delivered.”
The collaboration with Texas-based DocBox Inc. has led to the integration of their TriAge Assistant, a leading Internet of Medical Things (IoMT) platform for remote, real-time clinical monitoring. This integration elevates UniDoc’s diagnostics and communications capabilities, providing advanced connectivity and productivity between doctors, clinicians, and patients. The UniDoc platform, now enhanced with predictive algorithms and AI, is aiming to transform eHealth service delivery, improving access to high-quality care.
Further solidifying its position in the industry, UniDoc entered into a milestone OEM agreement with HP Inc. on February 28, 2024. This agreement allows for the integration of HP products into UniDoc’s H3 Health Cube and Virtual Care Solutions Model (VCSM), with global sales and distribution through HP’s extensive network. This partnership aligns with UniDoc’s goal of offering unique and accessible healthcare solutions worldwide.
Moreover, the reseller agreement with MediOrbis, a leading digital health company, enables UniDoc to offer an extensive network of specialty physicians. This collaboration is a significant step towards providing comprehensive, AI-enhanced eHealth care and improving patient outcomes across various locations and demographics.
UniDoc’s VCSM kiosks, in collaboration with MediOrbis, offer a suite of services including Virtual Primary Care, Integrated Specialty Care, Chronic Disease Management, and more. This alliance is a testament to UniDoc’s commitment to delivering accessible, efficient, and high-quality healthcare solutions, no matter the location.
As UniDoc Health Corp. continues its journey, the company invites stakeholders and interested parties to engage, ask questions, and stay informed through its website, www.unidoctor.com, and social media channels.
On Behalf of the Board of Directors,
~Antonio Baldassarre~
Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: investors@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: info@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “will be”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company transitioning from the development to commercialization stage, and the features and benefits to be included in the Company’s products and their ability to improve healthcare delivery.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company’s annual management discussion and analysis dated July 31, 2023 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.